Cancer stem cells in immunoregulation and bypassing anti-checkpoint therapy

Cancer stem cells in immunoregulation and bypassing anti-checkpoint therapy

Tumor microenvironment (TME) takes critical roles in tumor resistance to immune checkpoint inhibitors (ICIs) including anti-programmed death-1 (PD-1) or anti-programmed death-ligand 1 (PD-L1). Cancer stem cells (CSCs) are one of the key components of TME that play important roles in immunoregulation...

Full description

Bibliographic Details
Main Authors: Elnaz Rouzbahani, Jamal Majidpoor, Sajad Najafi, Keywan Mortezaee
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Cancer stem cell (CSC)
Programmed death-ligand 1 (PD-L1)
Programmed death-1 (PD-1)
Transforming growth factor-β (TGF-β)
Immune checkpoint inhibitor (ICI)
Tumor microenvironment (TME)
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332222012951

Internet

http://www.sciencedirect.com/science/article/pii/S0753332222012951

Similar Items